alphaveADVENZYMES₹302.20

Advanced Enzyme Tech Ltd.

₹ CrorePeersAARTIPHARM AARTIDRUGS AGARWALEYE AKUMS ALIVUS APLLTD CORONA HCGMcap ₹3,382 Cr

View

In ₹ Crore except Per Share 12 Months Ending	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/06/2026
Non-current Assets
+ Property, Plant & Equipment	276.5	292.9	275.8	275.8
+ Capital Work-in-Progress	30.7	21.7	51.2	51.2
+ Goodwill	325.3	333.4	369.5	369.5
+ Other Intangibles	47.9	52.3	46.9	46.9
+ Intangibles under Development	10.4	0.0	0.0	0.0
+ Non-current Investments	0.2	0.1	0.1	0.1
+ Long-term Loans	0.0	0.1	0.1	0.1
+ Other Non-current Financial Assets	4.2	9.9	9.7	9.7
Non-current Financial Assets	4.4	10.0	9.8	9.8
+ Deferred Tax Assets	26.6	10.2	4.9	4.9
+ Other Non-current Assets	3.9	20.9	37.1	37.1
Total Non-current Assets	725.7	741.5	795.2	795.2
Current Assets
+ Inventories	148.5	157.3	177.3	177.3
+ Current Investments	402.9	480.3	583.8	583.8
+ Trade Receivables	98.6	115.4	145.0	145.0
+ Cash & Cash Equivalents	113.8	94.2	108.8	108.8
+ Other Bank Balances	29.7	13.5	7.2	7.2
+ Short-term Loans	0.1	0.1	0.2	0.2
+ Other Current Financial Assets	3.2	8.0	8.6	8.6
Current Financial Assets	648.2	711.5	853.6	853.6
+ Other Current Assets	12.8	11.1	12.6	12.6
Total Current Assets	809.7	879.9	1,043.6	1,043.6
Total Assets	1,535.5	1,621.3	1,838.8	1,838.8
Equity
+ Equity Share Capital	22.4	22.4	22.4	22.4
+ Other Equity / Reserves	1,301.8	1,398.5	1,609.6	1,609.6
Equity — Owners of Parent	1,324.1	1,420.9	1,632.0	1,632.0
+ Minority Interest	47.0	47.8	51.2	51.2
Total Equity	1,371.1	1,468.7	1,683.1	1,683.1
Liabilities
+ Borrowings — Non-current	7.0	9.2	7.9	7.9
+ Other Non-current Financial Liab	15.9	11.7	3.8	3.8
Non-current Financial Liabilities	22.8	20.9	11.7	11.7
+ Provisions — Non-current	0.9	1.4	5.4	5.4
+ Deferred Tax Liabilities	34.3	33.6	31.9	31.9
Non-current Liabilities	58.0	55.9	48.9	48.9
+ Borrowings — Current	18.2	12.4	12.6	12.6
+ Trade Payables	15.8	17.2	40.0	40.0
+ Other Current Financial Liab	30.0	32.7	36.2	36.2
Current Financial Liabilities	64.0	62.3	88.8	88.8
+ Provisions — Current	19.7	21.4	6.4	6.4
+ Current Tax Liabilities	9.1	4.6	1.0	1.0
+ Other Current Liabilities	13.6	8.5	10.5	10.5
Current Liabilities	106.4	96.8	106.7	106.7
Total Liabilities	164.4	152.7	155.6	155.6
Total Equity & Liabilities	1,535.5	1,621.3	1,838.8	1,838.8
Assets — additional as-filed lines
+ Current Tax Assets	0.3	0.0	12.6	12.6
Trade Payables — MSME split
+ Dues to Micro & Small — Current	—	4.3	6.4	6.4
+ Dues to Other Creditors — Current	—	12.9	33.6	33.6

As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.